Showing results (1021-1030 of 10,077) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|May 29, 2012
Molecular link mechanisms between inflammation and cancerD B Vendramini-Costa, J E CarvalhoCurrent Pharmaceutical Design|May 29, 2012
Non-steroidal anti-inflammatory drugs and melanomaVirginia Sanz-Motilva, Antonio Martorell-Calatayud, Eduardo NagoreCurrent Pharmaceutical Design|May 29, 2012
TGF-β1 signalling, connecting aberrant inflammation and colorectal tumorigenesisVictoria R Skeen, Ian Paterson, Christos Paraskeva, et al.Current Pharmaceutical Design|May 29, 2012
Chemoprevention with phytonutrients and microalgae products in chronic inflammation and colon cancerElena Talero, Javier Ávila-Roman, Virginia MotilvaCurrent Pharmaceutical Design|May 22, 2012
Lipoic acid metabolism of Plasmodium--a suitable drug targetJanet Storm, Sylke MüllerCurrent Pharmaceutical Design|May 22, 2012
Novel drug targets in malaria parasite with potential to yield antimalarial drugs with long useful therapeutic livesFrancis W Muregi, Hannah Nyakio Wamakima, Francis T KimaniCurrent Pharmaceutical Design|May 22, 2012
Inhibition of protein-protein interactions in Plasmodium falciparum: future drug targetsChristine Pierrot, Aline Fréville, Christophe Olivier, et al.Current Pharmaceutical Design|May 11, 2012
Perspective of cyclin-dependent kinase 9 (CDK9) as a drug targetVladimír Krystof, Sonja Baumli, Robert FürstCurrent Pharmaceutical Design|May 11, 2012
Selective VEGFR inhibitors for anticancer therapeutics in clinical use and clinical trialsCunlong Zhang, Chunyan Tan, Huaiwei Ding, et al.Current Pharmaceutical Design|May 11, 2012
New directions in targeting protein kinases: focusing upon true allosteric and bivalent inhibitorsVandana Lamba, Indraneel GhoshPageof 1,008